Back to all news
AI Model Predicts Microsatellite Instability and Immunotherapy Response from Histology
Yonsei University researchers introduced MSI-SEER, an AI model for MSI and immunotherapy response prediction from histology images of gastric and colorectal cancers.
Key Details
- 1MSI-SEER uses deep Gaussian process modeling to analyze H&E-stained whole-slide images.
- 2The model integrates uncertainty quantification, providing a Bayesian Confidence Score for each prediction.
- 3MSI-SEER flags uncertain cases for human review to enhance reliability and safety.
- 4Validated on large, racially diverse datasets, it achieved state-of-the-art MSI prediction accuracy.
- 5The model also predicts immune checkpoint inhibitor (ICI) response, integrating tumor MSI status and stroma-to-tumor ratio.
- 6Published in npj Digital Medicine on May 19, 2025.
Why It Matters
This innovation demonstrates the power of AI in pathology to provide clinically actionable predictions and to integrate uncertainty for safer AI-human collaboration in cancer diagnosis and therapy selection. The approach may serve as a model for broader use of AI in precision oncology workflows.
Source
EurekAlert
Related News
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.